Dr. Ralf Weiskirchen is a full professor and the head of the Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) at RWTH University Aachen. He obtained his PhD from the Institute of Biochemistry, Medical Faculty, University of Cologne in 1994. With a strong academic background and extensive research experience, he has expertise in various biological disciplines, such as molecular biology, microbiology, biochemistry, pharmacology, and genetics. His primary research focus is on understanding the molecular mechanisms involved in the development of hepatic diseases. Specifically, he investigates the immunobiology of the liver, ranging from its healthy state to chronic inflammation, fibrosis, cirrhosis, and cancer. He places special emphasis on studying cytokine/chemokine activities and identifying new laboratory biomarkers for specific conditions. In recognition of his contributions, he was selected for inclusion in the 2024 Highly Cited Researchers list from Clarivate.